Cellular Biomedicine Group Reports Full-Year 2017 Financial Results and Recent Operational Progress

returns-focused private equity firm initiated by Shanghai International Group – the financial holding group of the Shanghai Municipal Government – became a significant investor in the Company. Cash Position: The Company had working capital of $20.9 …
( read original story …)